Click for best price

COVID19 RNA Vaccine Market Size, Share 2023

RNA vaccines are leading the way in vaccines because they are particularly well suited to rapid development.Although no RNA vaccine has yet been approved, the threat of a pandemic is a great incentive to accelerate its progress.RNA vaccines consist of mrna strands.They are injected into the body, usually wrapped in lipid nanoparticles.They fuse with cells.Once inside the cell, the RNA sequence is translated by the ribosome into a protein or part of a protein.

This report contains market size and forecasts of COVID-19 RNA Vaccine in Global, including the following market information:

Global COVID-19 RNA Vaccine Market Size 2024-2030, ($ millions)

The global COVID-19 RNA Vaccine market is projected to reach US$ million by 2029.

We surveyed the COVID-19 RNA Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global COVID-19 RNA Vaccine Market, by Type, 2024-2030 ($ millions)

Global COVID-19 RNA Vaccine Market Segment Percentages, by Type

Being Developed

Preclinical

Clinical I

Clinical II

Global COVID-19 RNA Vaccine Market, by Application, 2024-2030 ($ millions)

Global COVID-19 RNA Vaccine Market Segment Percentages, by Application

Pharmaceutical And Biotechnology Companies

Hospital

Academic And Research Organizations

Other

Global COVID-19 RNA Vaccine Market, By Region and Country, 2024-2030 ($ Millions)

Global COVID-19 RNA Vaccine Market Segment Percentages, by region and country

United States

Europe

Asia

China

Rest of World

Competitor Analysis

The report also provides analysis of leading market participants including:

Further, the report presents profiles of competitors in the market, key players include:

MODERNA

CureVac

Zydus Cadila

BioNTech

Stermirna

Report Attributes	Report Details
Report Title	COVID-19 RNA Vaccine Market, Global Outlook and Forecast 2023-2030
Historical Year	2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year	2022
Forecast Year	2030
Number of Pages	65 Pages
Customization Available	Yes, the report can be customized as per your need.

1 Introduction to Research & Analysis Reports
1.1 COVID-19 RNA Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global COVID-19 RNA Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global COVID-19 RNA Vaccine Overall Market Size
2.1 Global COVID-19 RNA Vaccine Market Size: 2023 VS 2030
2.2 Global COVID-19 RNA Vaccine Market Size, Prospects & Forecasts: 2023-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key COVID-19 RNA Vaccine Players in Global Market
3.2 Global Companies COVID-19 RNA Vaccine Product & Technology
4 COVID-19 RNA Vaccine Companies Profiles
4.1 MODERNA
4.1.1 MODERNA Company Summary
4.1.2 MODERNA Business Overview
4.1.3 MODERNA COVID-19 RNA Vaccine Product Offerings & Technology
4.1.4 MODERNA COVID-19 RNA Vaccine R&D, and Plans
4.2 CureVac
4.2.1 CureVac Company Summary
4.2.2 CureVac Business Overview
4.2.3 CureVac COVID-19 RNA Vaccine Product Offerings & Technology
4.2.4 CureVac COVID-19 RNA Vaccine R&D, and Plans
4.3 Zydus Cadila
4.3.1 Zydus Cadila Company Summary
4.3.2 Zydus Cadila Business Overview
4.3.3 Zydus Cadila COVID-19 RNA Vaccine Product Offerings & Technology
4.3.4 Zydus Cadila COVID-19 RNA Vaccine R&D, and Plans
4.4 BioNTech
4.4.1 BioNTech Company Summary
4.4.2 BioNTech Business Overview
4.4.3 BioNTech COVID-19 RNA Vaccine Product Offerings & Technology
4.4.4 BioNTech COVID-19 RNA Vaccine R&D, and Plans
4.5 Stermirna
4.5.1 Stermirna Company Summary
4.5.2 Stermirna Business Overview
4.5.3 Stermirna COVID-19 RNA Vaccine Product Offerings & Technology
4.5.4 Stermirna COVID-19 RNA Vaccine R&D, and Plans
5 Sights by Region
5.1 By Region - Global COVID-19 RNA Vaccine Market Size, 2024 & 2030
5.2 By Region - Global COVID-19 RNA Vaccine Revenue, (2024-2030)
5.3 United States
5.3.1 Key Players of COVID-19 RNA Vaccine in United States
5.3.2 United States COVID-19 RNA Vaccine Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of COVID-19 RNA Vaccine in Europe
5.4.2 Europe COVID-19 RNA Vaccine Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of COVID-19 RNA Vaccine in China
5.5.2 China COVID-19 RNA Vaccine Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 By Type - Global COVID-19 RNA Vaccine Market Size Markets, 2024 & 2030
6.2 Being Developed
6.3 Preclinical
6.4 Clinical I
6.5 Clinical II
7 Sights by Application
7.1 By Application - Global COVID-19 RNA Vaccine Market Size, 2024 & 2030
7.2 Pharmaceutical And Biotechnology Companies
7.3 Hospital
7.4 Academic And Research Organizations
7.5 Other
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. COVID-19 RNA Vaccine Market Opportunities & Trends in Global Market
Table 2. COVID-19 RNA Vaccine Market Drivers in Global Market
Table 3. COVID-19 RNA Vaccine Market Restraints in Global Market
Table 4. Key Players of COVID-19 RNA Vaccine in Global Market
Table 5. Global Companies COVID-19 RNA Vaccine Product & Technology
Table 6. MODERNA Company Summary
Table 7. MODERNA COVID-19 RNA Vaccine Product Offerings
Table 8. CureVac Company Summary
Table 9. CureVac COVID-19 RNA Vaccine Product Offerings
Table 10. Zydus Cadila Company Summary
Table 11. Zydus Cadila COVID-19 RNA Vaccine Product Offerings
Table 12. BioNTech Company Summary
Table 13. BioNTech COVID-19 RNA Vaccine Product Offerings
Table 14. Stermirna Company Summary
Table 15. Stermirna COVID-19 RNA Vaccine Product Offerings
Table 16. By Region? Global COVID-19 RNA Vaccine Revenue, (US$, Mn), 2024 & 2030
Table 17. By Region - Global COVID-19 RNA Vaccine Revenue, (US$, Mn), 2024-2030
Table 18. By Type ? Global COVID-19 RNA Vaccine Market Size, (US$, Mn), 2024 & 2030
Table 19. By Application? Global COVID-19 RNA Vaccine Market Size, (US$, Mn), 2024 & 2030
List of Figures
Figure 1. COVID-19 RNA Vaccine Segment by Type in 2030
Figure 2. COVID-19 RNA Vaccine Segment by Application in 2030
Figure 3. Global COVID-19 RNA Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global COVID-19 RNA Vaccine Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global COVID-19 RNA Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. By Region - Global COVID-19 RNA Vaccine Revenue Market Share, 2024-2030
Figure 8. By Type - Global COVID-19 RNA Vaccine Revenue Market Share, 2024-2030
Figure 9. By Application - Global COVID-19 RNA Vaccine Revenue Market Share, 2024-2030

DOWNLOAD SAMPLE

Download
Free Sample

Request
Customization

Check
Discount

REPORT PURCHASE OPTIONS

Single User Price : $3095

Multi User Price : $4024

Enterprise Price : $4643

---- OR ----

Frequently Asked Questions ?

Delivery Time

Upto 24 hrs - Working days
Upto 48 hrs max - Weekends and public holidays

User License

Single User License
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

Multi user License
A license granted to multiple users.

Site License
A license granted to a single business site/establishment.

Corporate License, Global License
A license granted to all employees within organisation access to the product.

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

Our Key Features

Data Accuracy and Reliability
Data Security
Customized Research
Trustworthy
Competitive Offerings

COVID-19 RNA Vaccine Market, Global Outlook and Forecast 2023-2030